|
Name |
Siderin
|
Molecular Formula | C12H12O4 | |
IUPAC Name* |
4,7-dimethoxy-5-methylchromen-2-one
|
|
SMILES |
CC1=CC(=CC2=C1C(=CC(=O)O2)OC)OC
|
|
InChI |
InChI=1S/C12H12O4/c1-7-4-8(14-2)5-10-12(7)9(15-3)6-11(13)16-10/h4-6H,1-3H3
|
|
InChIKey |
LLTOPKQGFAAMKH-UHFFFAOYSA-N
|
|
Synonyms |
siderin; Siderine; 4,7-dimethoxy-5-methylcoumarin; NK2BFZ89XC; 2H-1-Benzopyran-2-one, 4,7-dimethoxy-5-methyl-; 53377-54-1; 4,7-dimethoxy-5-methyl-chromen-2-one; UNII-NK2BFZ89XC; SCHEMBL4274099; DTXSID30968023; 4,7-dimethoxy-5-methyl-2H-chromen-2-one; 4,7-Dimethoxy-5-methyl-2H-1-benzopyran-2-one; Q15427829
|
|
CAS | 53377-54-1 | |
PubChem CID | 185740 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 220.22 | ALogp: | 1.9 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 44.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 16 | QED Weighted: | 0.73 |
Caco-2 Permeability: | -4.762 | MDCK Permeability: | 0.00003190 |
Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.361 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.985 |
Blood-Brain-Barrier Penetration (BBB): | 0.264 | Plasma Protein Binding (PPB): | 78.86% |
Volume Distribution (VD): | 0.913 | Fu: | 16.65% |
CYP1A2-inhibitor: | 0.969 | CYP1A2-substrate: | 0.968 |
CYP2C19-inhibitor: | 0.553 | CYP2C19-substrate: | 0.799 |
CYP2C9-inhibitor: | 0.174 | CYP2C9-substrate: | 0.88 |
CYP2D6-inhibitor: | 0.328 | CYP2D6-substrate: | 0.919 |
CYP3A4-inhibitor: | 0.329 | CYP3A4-substrate: | 0.395 |
Clearance (CL): | 10.969 | Half-life (T1/2): | 0.695 |
hERG Blockers: | 0.062 | Human Hepatotoxicity (H-HT): | 0.302 |
Drug-inuced Liver Injury (DILI): | 0.628 | AMES Toxicity: | 0.254 |
Rat Oral Acute Toxicity: | 0.065 | Maximum Recommended Daily Dose: | 0.153 |
Skin Sensitization: | 0.266 | Carcinogencity: | 0.065 |
Eye Corrosion: | 0.654 | Eye Irritation: | 0.985 |
Respiratory Toxicity: | 0.207 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005000 | 0.678 | D06GCK | 0.361 | ||||
ENC006013 | 0.619 | D0G4KG | 0.347 | ||||
ENC001442 | 0.552 | D0FA2O | 0.338 | ||||
ENC004845 | 0.545 | D09GYT | 0.313 | ||||
ENC003430 | 0.545 | D01XNB | 0.276 | ||||
ENC002205 | 0.535 | D0C6DT | 0.276 | ||||
ENC000962 | 0.522 | D0AO5H | 0.275 | ||||
ENC003879 | 0.506 | D02XJY | 0.274 | ||||
ENC005277 | 0.500 | D06QKV | 0.269 | ||||
ENC002134 | 0.486 | D08SKH | 0.268 |